Astragaloside IV Ameliorates Cerebral Ischemic-Reperfusion Injury via Improving Mitochondrial Function and Inhibiting Neuronal Apoptosis
Current Issues in Molecular Biology · 29.07.2025 · 47 (8) · 597
DOI: 10.3390/cimb47080597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 29.07.2025. Verfasst von Tongtong He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Hebei University of Chinese Medicine, No. 3 Xingyuan Road, Luqua…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Province Natural Science Foundation Project, Hebei Province Administration of Traditional Chinese Medicine Research Plan Project, Hebei Province Graduate Innovation Support Project.
Abstract (Originalsprache)
Cerebral ischemic-reperfusion injury (CIRI) involves mitochondrial dysfunction, with mitophagy playing a key role. Astragaloside IV (AS-IV) shows neuroprotective potential; however, its mechanisms related to mitochondrial function and apoptosis remain unclear.
Methods
Using a rat MCAO/R model, we evaluated the AS-IV’s effects via neurological scores, TTC staining, and histopathology. Molecular assays and docking were used to analyze mitophagy (PINK1, Parkin, p62, ROS, Bcl-2, and BAX) and apoptosis markers.
Results
AS-IV improved neurological function, reduced infarct volume, and alleviated neuronal/mitochondrial damage. It upregulated PINK1/Parkin, decreased p62, and modulated Bcl-2/Bax. Docking confirmed AS-IV binds PINK1/Parkin with high affinity.
Conclusions
AS-IV protects against CIRI by regulating the PINK1/Parkin pathway, improving mitochondrial function, and inhibiting neuronal apoptosis, providing an experimental basis for the clinical use
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Hebei University of Chinese Medicine, No. 3 Xingyuan Road, Luquan District, Shijiazhuang 050200, China.
ORCID-Profile: Tongtong He
Förderung
- Hebei Province Natural Science Foundation Project
- Hebei Province Administration of Traditional Chinese Medicine Research Plan Project
- Hebei Province Graduate Innovation Support Project
- Hebei University of Chinese Medicine Yan Zhao Medical Research Project
- Hebei University of Chinese Medicine Provincial Higher Education Basic Scientific Research Business Fee Special Project
- Key Project of the Joint Fund for Innovation and Development of Traditional Chinese Medicine
Zitieren
APA
He, T., Zhou, X., Wang, X., Zhao, Y., Liu, Z., Gao, P., Gao, W., & Jin, X. (2025). Astragaloside IV Ameliorates Cerebral Ischemic-Reperfusion Injury via Improving Mitochondrial Function and Inhibiting Neuronal Apoptosis. Current Issues in Molecular Biology, 47(8), 597. https://doi.org/10.3390/cimb47080597
Vancouver
He T, Zhou X, Wang X, Zhao Y, Liu Z, Gao P, et al. Astragaloside IV Ameliorates Cerebral Ischemic-Reperfusion Injury via Improving Mitochondrial Function and Inhibiting Neuronal Apoptosis. Current Issues in Molecular Biology. 2025;47(8):597. doi:10.3390/cimb47080597
BibTeX
@article{He2025,
author = {He, Tongtong and Zhou, Xiaohong and Wang, Xiaorong and Zhao, Yanmeng and Liu, Zhenyi and Gao, Ping and Gao, Weijuan and Jin, Xiaofei},
title = {Astragaloside IV Ameliorates Cerebral Ischemic-Reperfusion Injury via Improving Mitochondrial Function and Inhibiting Neuronal Apoptosis},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {8},
pages = {597},
doi = {10.3390/cimb47080597}
}
EUVIMED